Clinical Trials and New Cancer Drug Development

Clinical Trials are research studies that involve people. Clinical Trials are the finishing step in a long process that begins with research in a lab. Before any new treatment is used with people in Clinical Trials, researchers work for many years to understand its effects on Cancer cells in the lab and in animals. They also try to figure out the side effects it may cause. Trials are available for all stages of Cancer. It is a myth that they are only for people who have advanced Cancer that is not responding to treatment.

The Discovery and Development of Anticancer Drugs, especially cytotoxic agents, differ significantly from the Drug Development Process for any other indication. The unique challenges and opportunities in working with these agents are reflected in each stage of the Drug Development Process.

  • Advancements in Clinical Trials for Drug Development
  • Preclinical and Clinical research for cancer therapies
  • Cancer Clinical Trials protocol development
  • Cancer clinical trials case reports
  • Cancer Clinical trials data management
  • Guidelines for Cancer Clinical trials
  • Drug Discovery & Development
  • Regulation of Cancer Drugs
  • Pharmacovigilance aspects of Cancer drugs

Related Conference of Clinical Trials and New Cancer Drug Development

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Clinical Trials and New Cancer Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in